SCHEMBL6449520

SCHEMBL6449520

NCC(Cc1ccc(Cl)cc1)Cc1ccc(Cl)cc1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 2/20 0.60
SLC6A2 P23975 2/20 0.56
SLC6A3 Q01959 2/20 0.56
TAAR1 Q96RJ0 1/20 0.50
CYP2D6 P10635 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C19 P33261 1/20 0.44
MAOB P27338 3/20 0.43
IDO1 P14902 3/20 0.43
AGXT P21549 2/20 0.43
CHRNA4 P43681 2/20 0.42
CHRNB2 P17787 1/20 0.42
HTR2A P28223 1/20 0.40
HRH1 P35367 1/20 0.40
HTR2B P41595 1/20 0.40
PPARG P37231 1/20 0.39
PPARA Q07869 1/20 0.39
LMNA P02545 1/20 0.38
CYP2A6 P11509 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31648185 0.87 SLC6A4 (0.52) SLC6A4SLC6A2SLC6A3TAAR1CYP2D6
Hydrochloric Acid SCHEMBL31648401 0.86 SLC6A4 (0.50) SLC6A4SLC6A2SLC6A3TAAR1CYP2D6
SCHEMBL9921946 0.79 SLC6A4 (0.78) SLC6A4SLC6A2SLC6A3TAAR1CYP2D6
SCHEMBL3441646 0.79 SLC6A4 (0.78) SLC6A4SLC6A2SLC6A3TAAR1CYP2D6
SCHEMBL29129809 0.79 SLC6A4 (0.58) SLC6A4SLC6A2SLC6A3TAAR1CYP2D6
SCHEMBL9129267 0.79 SLC6A4 (0.52) SLC6A4SLC6A2SLC6A3TAAR1CYP2D6
Hydrochloric Acid SCHEMBL4291748 0.77 SLC6A4 (0.75) SLC6A4SLC6A2SLC6A3TAAR1CYP2D6
Hydrochloric Acid SCHEMBL4291743 0.77 SLC6A4 (0.75) SLC6A4SLC6A2SLC6A3TAAR1CYP2D6
SCHEMBL29498029 0.77 SLC6A4 (0.56) SLC6A4SLC6A2SLC6A3TAAR1CYP2D6
SCHEMBL232629 0.77 SLC6A2 (0.63) SLC6A4SLC6A2SLC6A3TAAR1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6890942-B2 Acyl sulfonamides as inhibitors of HIV integrase BRISTOL-MYERS SQUIBB COMPANY (US) 2005-05-10 US disclosed
US-20050004232-A1 Acyl sulfonamides as inhibitors of HIV integrase BRISTOL-MYERS SQUIBB COMPANY 2005-01-06 US disclosed
WO-2004103278-A2 ACYL SULFONAMIDES AS INHIBITORS OF HIV INTEGRASE BRISTOL-MYERS SQUIBB COMPANY (US) 2004-12-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004232-A1 Acyl sulfonamides as inhibitors of HIV integrase ACSS2, ARSA, ASS1 SLC6A4 3732/4885SLC6A2 3628/4885SLC6A3 3002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.